NCT00195468View on ClinicalTrials.gov

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Kidney FailureGraft vs Host Disease
Interventions
DRUG

CYCLOSPORINE

Trial Locations (13)

14000

Mexico City DF

27000

Torreón

80730-150

Curitiba

21041-030

Rio de Janeiro

21941-590

Rio de Janeiro

90020-090

Porto Alegre

90035-903

Porto Alegre

14048-900

Ribeirao Preto

15015-200

São José do Rio Preto

01323-001

São Paulo

04038-002

São Paulo

05403-000

São Paulo

Unknown

Chihuahua City

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195468 - Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus | Biotech Hunter | Biotech Hunter